Novel diamidino-substituted derivatives of phenyl benzothiazolyl and dibenzothiazolyl furans and thiophenes: synthesis, antiproliferative and DNA binding properties.
Novel Diamidino-Substituted Derivatives of Phenyl Benzothiazolyl and Dibenzothiazolyl Furans and Thiophenes Synthesis, Antiproliferative and DNA Binding Properties.pdf
[en] A series of new diamidino-, diisopropylamidino-, and diimidazolinyl-substituted derivatives of phenyl benzothiazolyl and dibenzothiazolyl furans and thiophenes were successfully prepared and evaluated for their antiproliferative activity on tumor cell lines in vitro, DNA binding propensity, and sequence selectivity as well as cellular distribution. A strong antiproliferative effect of the tested compounds was observed on all tested cell lines in a concentration-dependent response pattern. In general, imidazolinyl-substituted derivatives and/or the thiophene core were in correlation with increased antiproliferative activity. Two compounds (2b and 3b) were chosen for biological studies due to their differential antiproliferative properties. The DNA binding properties of this new series of compounds were assessed and evidenced their efficient minor groove binding properties with preferential interaction at AT-rich sites. Both compounds also present nuclear subcellular localization, suggesting that their cellular mode of action implies localization in the DNA compartment and direct inhibition of DNA replication and induction of apoptosis.
Novel diamidino-substituted derivatives of phenyl benzothiazolyl and dibenzothiazolyl furans and thiophenes: synthesis, antiproliferative and DNA binding properties.
Publication date :
2010
Journal title :
Journal of Medicinal Chemistry
ISSN :
0022-2623
eISSN :
1520-4804
Publisher :
American Chemical Society, Washington, United States - District of Columbia
Ban, M.; Taguchi, H.; Katsushima, T.; Takahashi, M.; Shinoda, K.; Watanabe, A.; Tominaga, T. Novel antiallergic and antiinflammatory agents. Part I: Synthesis and pharmacology of glycolic amide deriva-tives. Bioorg. Med. Chem. 1998, 6, 1069-1076.
Papadopoulou, C.; Geronikaki, A.; Hadjipavlou-Iitina, D. Synthesis and biological evaluation of new thiazolyl/benzothiazo-lyl-amides, derivatives of 4-phenyl-piperazine. Farmaco 2005, 60, 969-1912
Chung, Y.; Shin, Y.-K.; Zhan, C.-G.; Iee, S.; Cho, H. Synthesis and evaluation of antitumor activity of 2- and 6-[(l, 3-benzothiazol-2-yl) aminomethyl]-5, 8-dimethoxy-l, 4-naphthoquinone derivatives. Arch. Pharm. Res. 2004, 27, 893-900.
McFadyen, M. C. E.; Melvin, W. T.; Murray, G. I. Cytochrome P450 enzymes: novel options for cancer therapeutics. Mol. Cancer Ther. 2004, 3, 363-371.
Yoshida, M.; Hayakawa, I.; Hayashi, N.; Agatsuma, T.; Oda, Y.; Tanzawa, F.; Iwasaki, S.; Koyama, K.; Furukawa, H.; Kurakata, S. Synthesis and biological evaluation of benzothiazole derivatives as potent antitumor agents. Bioorg. Med. Chem. Lett. 2005, 15, 3328-3332.
Starčević, K.; Caleta, I.; Cinčić, D.; Kaitner, B.; Kralj, M.; Ester, K.; Karminski-Zamola, G. Synthesis, crystal structure determina-tion and antiproliferative evaluation of novel benzazoyl benza-mides. Heterocycles 2006, 68, 2285-2299.
Ćaleta, I; Kralj, M.; Bertoša, B.; Tomić, S.; Pavlović, G.; Pavelić, K.; Karminski-Zamola, G. Novel cyano and amidinobenzothiazole derivatives: synthesis, antitumor evaluationand X-ray quantitative structure-activity relationship (QSAR) analysis. J. Med. Chem. 2009, 52, 1744-1756.
Baell, J. B.; Forsyth, S. A.; Gable, R. W.; Norton, R. S.; Mulder, R. J. Design and synthesis of type-III mimetics of w-conotoxin GVIA. J. Comput.-Aided Mol. Des. 2002, 15, 1119-1136.
Westway, S. M.; Thompson, M.; Rami, H. K.; Stemp, G.; Trouw, I. S.; Mitchell, D. J.; Seal, J. T.; Medhurst, S. J.; Iappin, S. C.; Biggs, J.; Wright, J.; Arpino, S.; Jerman, J. C.; Cryan, J. E.; Holland, V.; Winborn, K. Y.; Coleman, T.; Stevens, A. J.; Davis, J. B.; Gunthorpe, M. J. Design and synthesis of 6-phenylnicotina-mide derivatives as antagonists of TRPV1. Bioorg. Med. Chem. Lett. 2008, 18, 5609-5613.
Das, J.; Iin, J.; Moquin, R. V.; Shen, Z.; Spergel, S. H.; Wityak, J.; Doweyko, A. M.; DeFex, H. F.; Fang, Q.; Pang, S.; Pitt, S.; Ren Shen, D.; Schieven, G. I.; Barrish, J. C. Molecular design, synth-esis, and structure-activity relationships leading to the potent and selective P56 1ck inhibitor BMS-243117. Bioorg. Med. Chem. Lett. 2003, 75, 2145-2149.
Das, J.; Moquin, R. V.; Iin, J.; Iiu, C.; Doweyko, A. M.; DeFex, H. F.; Fang, Q.; Pang, S.; Pitt, S.; Ren Shen, D.; Schieven, G. L.; Barrish, J. C.; Wityak, J. Discovery of 2-amino-heteroaryl-ben-zothiazole-6-anilides as potent p561ck inhibitors. Bioorg. Med. Chem. Lett. 2003, 13, 2587-2590.
Gaillard, P.; Jeanclaude-Etter, I; Ardissone, V.; Arkinstall, S.; Cambet, Y.; Camps, M.; Chabert, C.; Church, D.; Cirillo, R.; Gretener, D.; Halazy, S.; Nichols, A.; Szyndralewiez, C.; Vitte, P.-A.; Gotteland, J.-P. Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase. J. Med. Chem. 2005, 48, 4596-4607.
Iiu, C.; Iin, J.; Pitt, S.; Zhang, R. F.; Sack, J. S.; Kiefer, S. E.; Kish, K.; Doweyko, A. M.; Zhang, H.; Marathe, P. H.; Trzaskos, J.; Mckinnon, M.; Dodd, J. H.; Barrish, J. C.; Schieven, G. I.; Ieftheris, K. Benzothiazole based inhibitors of p38a MAP kinase. Bioorg. Med. Chem. Lett. 2008, 18, 1874-1879.
Pinar, A.; Yurdakul, P.; Yildiz, I; Temiz-Arpaci, O.; Acan, N. I.; Aki-Sener, E.; Yalcin, I. Some fused heterocyclic compounds as eukaryotic topoisomerase II inhibitors. Biochem. Biophys. Res. Commun. 2004, 317, 670-674.
Abdel-Aziz, M.; Matsuda, K.; Otsuka, M.; Uyeda, M.; Okawara, T.; Suzuki, K. Inhibitory activities against topoisomerase I & II by polyhydroxybenzoyl amide derivarives and their structure-activity relationship. Bioorg. Med. Chem. Lett. 2004, 14, 1669-1672.
Manjula, S. N.; Malleshappa, N.; Noolvi, K.; VipanParihar, S. A.; Reddy, M.; Ramani, V.; Gadad, A. K.; Singh, G. N.; Gopalan Kutty, C.; Rao, M. Synthesis and antitumor activity of optically active thiourea and their 2-aminobenzothiazole derivatives: a novel class of anticancer agents. Eur. J. Med. Chem. 2009, 44, 2923-2929.
Repicky, A.; Jantova, S.; Cipak, L. Apoptosis induced by 2-acetyl-3-(6-methoxybenzothiazo)-2-yl-amino-acrylonitrile in human leu-kemia cells involves ROS-mitochondrial mediated death signaling and activation of p38 MAPK. Cancer Lett. 2009, 277, 55-63.
Tasler, S.; Müller, O.; Wieber, T.; Herz, T.; Krauss, R.; Totzke, F.; Kubbutat, M. H. G.; Scháchtele, C. N-Substituted 2'-(aminoaryl)- benzothiazoles as kinase inhibitors: hit identification and scaffold hopping. Bioorg. Med. Chem. Lett. 2009, 19, 1349-1356.
Chaires, J. B.; Ren, J.; Hamelberg, D.; Kumar, A.; Pandya, V.; Boykin, D. W.; Wilson, W. D. Structural selectivity of aromatic diamidines. J. Med. Chem. 2004, 47, 5729-5742.
Cai, X.; Gray, P. J, Jr.; Von Hoff, D. D. DNA minor groove binders: back in the groove. Cancer Treat. Rev. 2009, 35, 437-450.
Lansiaux, A.; Dassonneville, L.; Facompré, M.; Kumar, A.; Stephens, C. E.; Bajic, M.; Tanious, F.; Wilson, W. D.; Boykin, D. W.; Bailly, C. Distribution of furamidine analogues in tumor cells: influence of the number of positive charges. J. Med. Chem. 2002, 45, 1994-2002.
Lansiaux, A.; Tanious, F; Mishal, Z.; Dassonneville, L.; Kumar, A.; Stephens, C. E.; Hu, Q.; Wilson, W. D.; Boykin, D. W.; Bailly, C. Distribution of furamidine analogues in tumor cells: targeting of the nucleus or mitochondria depending on the amidine substitu-tion. Cancer Res. 2002, 62, 7219-7229.
Munde, M.; Ismail, M. A.; Arafa, R.; Peixoto, P.; Collar, C. J.; Liu, Y.; Hu, L.; David-Cordonnier, M.-H.; Lansiaux, A.; Bailly, C.; Boykin, D. W.; Wilson, W. D. Design of DNA minor groove binding diamidines that recognize GC base pair sequences: a novel dimeric-hinge motif. J. Am. Chem. Soc. 2007, 129, 13732-13743.
Miao, Y.; Lee, M. P.; Parkinson, G. N.; Batista-Parra, A.; Ismail, M. A.; Neidle, S.; Boykin, D. W.; Wilson, W. D. Out-of-shape DNA minor groove binders: induced fit interactions of heterocyclic dications with the DNA minor groove. Biochemistry 2005, 44, 14701-14708.
Tanious, F. A.; Laine, W.; Peixoto, P.; Bailly, C.; Goodwin, K. D.; Lewis, M. A.; Long, E. C.; Georgiadis, M. M.; Tidwell, R. R.; Wilson, W. D. Unusually strong binding to the DNA minor groove by a highly twisted benzimidazole diphenylether: induced fit and bound water. Biochemistry 2007, 46, 6944-6956.
Racanè, L.; Tralić-Kulenović, V.; Kitson, R. P.; Karminski-Zamola, G. Synthesis and antiproliferative activity of cyano and amidino sub-stituted 2-phenylbenzothiazoles. Monatsh. Chem. 2006, 137, 1571-1577.
Racanè, L.; Stojković, R.; Tralić-Kulenović, V.; Karminski-Zamola, G. Synthesis and antitumor evaluation of novel derivatives of 6-amino-2-phenylbenzothiazoles. Molecules 2006, 11, 325-333.
Racanè, L.; Tralić-Kulenović, V.; Fišer-Jakić, L.; Boykin, W. D.; Karminski-Zamola, G. Synthesis of bis-substituted amidinoben-zothiazoles as potential anti-HIV agents. Heterocycles 2001, 55, 2085-2098.
Tralić-Kulenović, V; Karminski-Zamola, G.; Racanè, L.; Fišer-Jakić, L. Synthesis of symmetric and unsymetric bis cyanosubstituted hetero-cycles. Heterocycl. Commun. 1998, 4, 423-427.
Racanè, L.; Tralić-Kulenović, V.; Mihalić, Z.; Pavlović, G.; Karminski-Zamola, G. Synthesis of new amidino-substituted 2-aminothiophenole: mild basic ring opening of benzothiazole. Tetrahedron 2008, 64, 11594-11602.
Pinar, A.; Yurdakul, P.; Yildiz, I; Temi-Arpaci, O.; Acan, N. L.; Aki-Sener, E; Yalcin, I. Some fused heterocyclic compounds as eukaryotic topoisomerase II inhibitors. Biochem. Biophys. Res. Commun. 2004, 317, 670-674.
Abdel-Aziz, M.; Matsuda, K.; Otsuka, M.; Uyeda, M.; Okawara, T.; Suzuki, K. Inhibitory activities against topoisomerase I & II by ployhydroxybenzoyl amide derivatives and their structure-activity relationship. Bioorg. Med. Chem. Lett. 2004, 14, 1669-1672.
Okada, H.; Mak, T. W. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat. Rev. Cancer 2004, 4, 592-603.
Diaz, L. F.; Chiong, M.; Quest, A. F. G.; Lavandero, S.; Stutzin, A. Mechanisms of cell death: molecular insights and therapeutic perspectives. Cell Death Differ. 2005, 12, 1449-1456.
Zhang, J.; Cheng, C.; He, C.-L.; Zhou, Y.-J.; Cao, Y. The expres-sion of Bcl-XL, Bcl- XS and p27Kipl in topotecan-induced apop-tosis in hepatoblastoma HepG2 cell line. Cancer Invest. 2008, 26, 456-463.
Joe, A. K.; Liu, H.; Suzui, M.; Vural, M. E.; Xiao, D.; Weinstein, I. B. Resveratrol induces growth inhibition, S-phase arrest, apopto-sis, and changes in biomarker expression in several human cancer cell lines. Clin. Cancer Res. 2002, 8, 893-903.
Peixoto, P.; Bailly, C.; David-Cordonnier, M.-H. In Methods in Molecular Biology Series, Drug-DNA Interactions; Fox, K. R., Ed.; Humana Press: Totowa, NJ, 2010; Vol.613, pp 235-256.
Gazivoda, T.; Raić-Malić, S.; Krištafor, V.; Makuc, D.; Plavec, J.; Bratulic, S.; Kraljević Pavelić, S.; Pavelić, K.; Naesens, L.; Andrei, G.; Snoeck, R.; Balzarini, J.; Mintas, M. The novel pyrimidine and purine derivatives of 1-ascorbic acid: synthesis, one- and two-dimensional 1H and 13C NMR study, cytostatic and antiviral evaluation. Bioorg. Med. Chem. 2008, 16, 5624-5634.
Peixoto, P.; Liu, Y.; Depauw, S.; Hildebrand, M.-P.; Boykin, D. W.; Bailly, C.; Wilson, W. D.; David-Cordonnier, M.-H. Direct inhibition of the DNA-binding activity of POU transcrip-tion factors Pit-1 and Brn-3 by selective binding of a phenyl-furan-benzimidazole dication. Nucleic Acids Res. 2008, 36, 3341-3353.
